Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
PGEN · against 385 other Healthcare companies of similar size
Ranked #21 of 386 · scores higher than 94% of peers
Bars: peers in each 10-point band of the growth score37 peers with a growth score of 90–100, including PGEN · Click a bar to see the companies
Mainly thanks to its revenue growth and 3-year revenue growth, which are stronger than most Healthcare peers.
| Metric | PGEN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 387 reported | 146.7% | 6.2% | 96% | 33% | |
| Earnings per share growthHigher is better · 217 reported | Not reported | 7.9% | — | — | 33% |
| 3-year revenue growthHigher is better · 378 reported | 57.1% | 6.9% | 94% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 2 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 2 | 1.4B USD | 99 | 73 | |
| 2 | 27.6B SEK (≈$2.8B) | 99 | 76 | |
| 2 | 2.1B USD | 99 | 96 | |
| 15 | 1.6B USD | 95 | 38 | |
| 15 | 2.0B USD | 95 | 53 | |
| 15 | 1.3B USD | 95 | 33 | |
| 21 | 1.6B USD | 94 | 52 | |
| 21 | 1.9B USD | 94 | 32 | |
| 21 | 1.7B USD | 94 | 31 | |
| 24 | 22.1B CNY (≈$3.1B) | 93 | 49 | |
| 24 | 1.7B USD | 93 | 46 | |
| 24 | 1.5B USD | 93 | 32 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score